Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 13;8(4):616.
doi: 10.18063/ijb.v8i4.616. eCollection 2022.

3D Bioprinting for Regenerating COVID-19-Mediated Irreversibly Damaged Lung Tissue

Affiliations
Review

3D Bioprinting for Regenerating COVID-19-Mediated Irreversibly Damaged Lung Tissue

Fariya Akter et al. Int J Bioprint. .

Abstract

While the tension of COVID-19 is still increasing, patients who recovered from the infection are facing life-threatening consequences such as multiple organ failure due to the presence of angiotensin-converting enzyme 2 receptor in different organs. Among all the complications, death caused by respiratory failure is the most common because severe acute respiratory syndrome coronavirus 2 infects lung's type II epithelial, mucociliary, and goblet cells that eventually cause pneumonia and acute respiratory distress syndrome, which are responsible for the irreversible lung damage. Risk factors, such as age, comorbidities, diet, and lifestyle, are associated with disease severity. This paper reviews the potential of three-dimensional bioprinting in printing an efficient organ for replacement by evaluating the patient's condition.

Keywords: 3D bioprinting; COVID-19; Irreversible heart tissue damage; Regenerative medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest regarding the publication of the manuscript.

Figures

Figure 1
Figure 1
Different techniques of 3D bioprinting.

Similar articles

Cited by

References

    1. Stadler K, Masignani V, Eickmann M, et al. SARS--Beginning to Understand a New Virus. Nat Rev Microbiol. 2003;1:209–18. https://doi.org/10.1038/nrmicro775. - PMC - PubMed
    1. Mackay IM, Arden KE. MERS Coronavirus:Diagnostics, Epidemiology and Transmission. Virol J. 2015;12:222. https://doi.org/10.1186/s12985-015-0439-5. - PMC - PubMed
    1. Jin Y, Yang H, Ji W, et al. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 2020;12:372. https://doi.org/10.3390/v12040372. - PMC - PubMed
    1. Wang C, Horby PW, Hayden FG, et al. A Novel Coronavirus Outbreak of Global Health Concern. Lancet (London, England) 395:470–3. https://doi.org/10.1016/S0140-6736(20)30185-9. - PMC - PubMed
    1. Zhou F, Yu T, Du R, et al. Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China:A Retrospective Cohort Study. Lancet. 2020;395:1054–62. https://doi.org/10.1016/S0140-6736(20)30566-3. - PMC - PubMed

LinkOut - more resources